Do not mix adequan canine with other drugs or solvents.
Adequan dosage for canines.
Although improvement is generally observed after the second injection cartilage erosion ceases after the.
Your veterinarian will determine the appropriate dose for your pet.
Veterinarians may repeat the 1 4 7 series as needed upon recurrence of the clinical signs of djd.
Adverse reactions in clinical studies transient pain at injection site transient diarrhea and abnormal bleeding were mild and self limiting.
1 2 after the initial series veterinarians and owners alike should keep monitoring the horse s joint health and mobility.
It is a useful medication post surgery and is fast acting.
The recommended dose of adequan canine is 2 mg lb body weight 02 ml lb or 1 ml per 50 lb by intramuscular injection only twice weekly for up to 4 weeks maximum of 8 injections.
The recommended dosage is 2mg per pound of the dog s weight.
Adequan helps relieve the pain of arthritis by soothing and lubricating the inflamed joint in addition to stimulating joint cartilage repair.
Adequan canine is the only fda approved injectable disease modifying osteoarthritis drug dmoad for dogs.
This dose of adequan canine should be injected intramuscularly twice a week for 4 weeks.
Do not exceed the recommended dose or therapeutic regimen.
Important safety information adequan canine should not be used in dogs who are hypersensitive to psgag or who have a known or suspected bleeding disorder.
Currently adequan is only fda approved for dogs and horses though some vets do prescribe it for cats as well.
Read on to learn about adequan for dogs the correct dosage safety precautions side effects and uses of the medicine.
It should be used with caution in dogs with renal or hepatic impairment.
The recommended dose of adequan canine is 2 mg lb body weight 02 ml lb or 1 ml per 50 lb by intramuscular injection only twice weekly for up to 4 weeks maximum of 8 injections.
Adequan canine is a medication for the treatment of arthritis in dogs.
It has to be administered in a series of 8 injections.
The drug works by inhibiting one of the enzymes responsible for breaking down.
At the approved dose 500 mg to achieve improvement shown in studies.
2 do not exceed the recommended dose or therapeutic regimen.
Use adequan canine early at the first clinical signs of oa before it progresses and cartilage is irreversibly damaged.
It is recommended for the control of signs associated with non infectious degenerative and or traumatic arthritis of canine synovial joints.
At early signs of degenerative joint disease veterinarians can administer adequan i m.
Administer twice weekly for up to 4 weeks maximum of 8 injections at approved dosage of 2 mg lb body weight 0 02 ml lb or 1 ml 50 lb by intramuscular im injection only.
